Predicting Severe COVID-19 Outcomes in the Elderly: The Role of Systemic Immune Inflammation, Liver Function Tests, and Neutrophil-to-Lymphocyte Ratio.

Predicting Severe COVID-19 Outcomes in the Elderly: The Role of Systemic Immune Inflammation, Liver Function Tests, and Neutrophil-to-Lymphocyte Ratio.

Publication date: Dec 03, 2024

Background: Patients aged 80 years and above are at increased risk for severe COVID-19 outcomes. This study aimed to evaluate the prognostic utility of the derived neutrophil-to-lymphocyte ratio (dNLR), aspartate-aminotransferase-to-lymphocyte ratio index (ALRI), aspartate-aminotransferase-to-platelet ratio index (APRI), and systemic immune inflammation index (SII) in predicting severe disease, intensive care unit (ICU) admission, and mortality among COVID-19 patients aged 80 years and older. Methods: In this retrospective cohort study, 138 elderly patients (≥80 years) and 215 younger controls (

Open Access PDF

Concepts Keywords
Aminotransferase COVID-19
Basel intensive care
Covid mortality
Elderly prediction
Lymphocyte SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
disease IDO role
disease MESH Inflammation
drug DRUGBANK Coenzyme M

Original Article

(Visited 1 times, 1 visits today)